Resmed Inc (RMD)

Index:

ASX 100

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $27.65
  • Currency: Australian Dollars
  • Shares Issued: 1,426.80m

Resmed Inc Overview

ResMed is a developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing (SDB) and other respiratory disorders. It operates in over 65 countries

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.7%
Div Cover 10.3
Op Mrgn 21.5%
ROCE 21.5%
Latest F'cast
P/E 13.1
PEG 0.8
Pr/Revenue 24.0
Pr/Book 20.4
Latest F'cast
Revenue 10.1%
PBT 9.3%
EPS 17.4%
DPS n/a

Resmed Inc Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-08 835.40 157.85 71.50¢ n/a n/a +66% n/a 0.0%
30-Jun-09 920.73 201.68 97.00¢ n/a n/a +36% n/a 0.0%
30-Jun-10 1,092.36 260.59 126.00¢ n/a n/a +30% n/a 0.0%
30-Jun-11 1,243.15 303.71 149.00¢ n/a n/a +18% n/a 0.0%
30-Jun-12 1,368.52 331.95 175.00¢ n/a n/a +17% 17.00¢ 0.0%

Resmed Inc Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 5,122.73 1,724.84 1,487.34¢ 2.4 0.0 +443% 350.93¢ 0.0%
30-Jun-26 5,517.68 1,888.79 1,636.51¢ 2.2 0.2 +10% 393.76¢ 0.0%
30-Jun-27 5,921.59 2,049.45 1,791.85¢ 2.0 0.2 +10% 394.36¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Resmed Inc Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $27.65
Shares Issued 1,426.80m

What The Brokers Say

Strong Buy 4
Buy 6
Neutral 5
Sell 1
Strong Sell 1
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page